In Vitro Topical and Cosmetics Testing
Cyprotex performs a wide variety of in vitro safety testing for pharmaceutical companies developing topical therapeutics, and for the cosmetics and consumer-products industries.
Contact us for help on your cosmetics and topical testing needs.
Our cosmetics and topical tests assess for:
Our safety assessment methods are in accordance with the 7th Amendment to the Cosmetics Directive for companies developing topical pharmaceuticals. Many of our studies are based on MatTek tissue models, for which Cyprotex is a MatTek-approved laboratory. Our skin irritation and phototoxicity protocols follow the standardised test procedures within the OECD guidelines.
Cyprotex can also customise assays for your particular topical or cosmetic safety testing needs.
Contact us for help on your topical testing or cosmetic product testing needs.
Genomic ADME - gADME™
Cyprotex's proprietary gADME™ system can alert you to genetic variations in drug metabolism, allowing for personalised doses, drug rescue and repositioning.
Learn more about gADME
In vitro Micronucleus Test
Cyprotex now offers the in vitro micronucleus test for genotoxicity assessment using an automated, high content screening method for improved detection and reliability.
Learn more about our in vitro MNT service
Drug Transporters
Cyprotex provides a full range of drug-transporter studies as recommended by the ITC white paper and EMA guidelines.
Learn more about transporters
By Dr. Katya Tsaioun, Chief Scientific Officer, Cyprotex
Wiley & Sons, March 2011
